Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, Department of Pathophysiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
Int J Mol Sci. 2023 Oct 7;24(19):14982. doi: 10.3390/ijms241914982.
The high morbidity and mortality rates associated with sepsis highlight the challenges of finding specific remedies for this condition in the intensive care unit (ICU). This study aimed to explore the differentially expressed genes (DEGs) specific to cell types in sepsis and investigate the role of resistin in the survival of sepsis patients through Mendelian randomization (MR) analyses. We used single-cell and bulk transcriptome data to identify cell type-specific DEGs between sepsis and healthy controls. MR analyses were then conducted to investigate the causal relationships between resistin (one of the identified DEGs) levels and the survival of sepsis patients. Additionally, we utilized meQTL (methylation quantitative trait loci) to identify cytosine-phosphate-guanine (CpG) sites that may directly affect sepsis. We identified 560 cell type-specific DEGs between sepsis and healthy controls. Notably, we observed the upregulation of resistin levels in macrophages during sepsis. In bulk transcriptome, RETN is also upregulated in sepsis samples compared with healthy controls. MR analyses revealed a negative association existed between the expression of resistin, at both gene and protein levels, and the mortality or severity of sepsis patients in ICU. Moreover, there were no associations observed between resistin levels and death or organ failure due to other causes. We also identified three methylation CpG sites, located in RETN or its promoter region-cg06633066, cg22322184, and cg02346997-that directly affected both resistin protein levels and sepsis death in the ICU. Our findings suggest that resistin may provide feasible protection for sepsis patients, particularly those with severe cases, without serious side effects. Therefore, resistin could be a potential drug candidate for sepsis treatment. Additionally, we identified two CpG sites, cg06633066 and cg22322184, that were associated with RETN protein levels and sepsis death, providing novel insights into the underlying mechanisms of sepsis.
脓毒症的高发病率和死亡率突出表明,在重症监护病房(ICU)中寻找针对这种疾病的特定治疗方法存在挑战。本研究旨在通过孟德尔随机分析(MR)研究探索脓毒症中特定细胞类型差异表达的基因(DEGs),并研究抵抗素在脓毒症患者生存中的作用。我们使用单细胞和批量转录组数据来识别脓毒症和健康对照之间特定于细胞类型的 DEGs。然后进行 MR 分析以研究抵抗素(鉴定的 DEGs 之一)水平与脓毒症患者生存之间的因果关系。此外,我们利用 meQTL(甲基化数量性状位点)来鉴定可能直接影响脓毒症的胞嘧啶-磷酸-鸟嘌呤(CpG)位点。我们在脓毒症和健康对照之间鉴定了 560 个特定于细胞类型的 DEGs。值得注意的是,我们观察到在脓毒症期间巨噬细胞中抵抗素水平上调。在批量转录组中,与健康对照组相比,RETN 在脓毒症样本中也上调。MR 分析表明,在 ICU 中,抵抗素的表达(在基因和蛋白水平上)与脓毒症患者的死亡率或严重程度之间存在负相关。此外,在抵抗素水平与其他原因导致的死亡或器官衰竭之间没有观察到关联。我们还鉴定了三个位于 RETN 或其启动子区域 cg06633066、cg22322184 和 cg02346997 的甲基化 CpG 位点,这些位点直接影响抵抗素蛋白水平和 ICU 中的脓毒症死亡。我们的研究结果表明,抵抗素可能为脓毒症患者提供可行的保护,特别是那些严重病例,而没有严重的副作用。因此,抵抗素可能是脓毒症治疗的潜在候选药物。此外,我们鉴定了两个 CpG 位点 cg06633066 和 cg22322184,它们与 RETN 蛋白水平和脓毒症死亡相关,为脓毒症的潜在机制提供了新的见解。